Paper3916740
Complete androgen blockade for the treatment of prostate cancer.
Labrie F and 2 others. Important Adv Oncol, 1985. Cited by 136 papers, by iCite.
Cite this record
ConductScience Library. Complete androgen blockade for the treatment of prostate cancer. Papers, record 3916740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3916740
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenalectomy | Major topic |
| Androgen Antagonists | Major topic |
| Androgens | Major topic |
| Antineoplastic Agents | Major topic |
| Estrogens | Major topic |
| Gonadotropin-Releasing Hormone | Major topic |
| Neoplasms, Hormone-Dependent | Major topic |
| Orchiectomy | Major topic |
| Prostatic Neoplasms | Major topic |
| Acid Phosphatase | |
| Bone Neoplasms | |
| Combined Modality Therapy | |
| Drug Evaluation | |
| Humans | |
| Male |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33780276 | Baseline Testosterone Levels in Men with Clinically Localized High-Risk Prostate Cancer Treated with Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy (Alliance). | J Urol | 2021 | https://conductscience.org/library/papers/33780276 | PubMed |
| 33722247 | The inhibitory effect of melatonin on human prostate cancer. | Cell Commun Signal | 2021 | https://conductscience.org/library/papers/33722247 | PubMed |
| 32016080 | The importance of antiandrogen in prostate cancer treatment. | Ann Transl Med | 2019 | https://conductscience.org/library/papers/32016080 | PubMed |
| 31948021 | Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration? | Animals (Basel) | 2020 | https://conductscience.org/library/papers/31948021 | PubMed |
| 31504033 | Systematically understanding the immunity leading to CRPC progression. | PLoS Comput Biol | 2019 | https://conductscience.org/library/papers/31504033 | PubMed |
| 29440921 | Adult-onset acne: prevalence, impact, and management challenges. | Clin Cosmet Investig Dermatol | 2018 | https://conductscience.org/library/papers/29440921 | PubMed |
| 24303091 | Increased bone mineral density in patients with non-alcoholic steatohepatitis. | World J Hepatol | 2013 | https://conductscience.org/library/papers/24303091 | PubMed |
| 21243019 | Blockade of testicular and adrenal androgens in prostate cancer treatment. | Nat Rev Urol | 2011 | https://conductscience.org/library/papers/21243019 | PubMed |
| 17387321 | Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer. | Prostate Cancer Prostatic Dis | 2007 | https://conductscience.org/library/papers/17387321 | PubMed |
| 11988089 | Crystal structure of human dehydroepiandrosterone sulphotransferase in complex with substrate. | Biochem J | 2002 | https://conductscience.org/library/papers/11988089 | PubMed |
| 11173616 | Prostate Cancer Old Problems and New Approaches. Part III. Prevention and Treatment. | Pathol Oncol Res | 1996 | https://conductscience.org/library/papers/11173616 | PubMed |
| 10408706 | Controversies in the management of advanced prostate cancer. | Br J Cancer | 1999 | https://conductscience.org/library/papers/10408706 | PubMed |
| 10147438 | Clinical and economic considerations in the treatment of prostate cancer. | Pharmacoeconomics | 1994 | https://conductscience.org/library/papers/10147438 | PubMed |
| 9699133 | DHEA as physiological replacement therapy at menopause. | J Endocrinol Invest | 1998 | https://conductscience.org/library/papers/9699133 | PubMed |
| 9592622 | Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9592622 | PubMed |
| 9241550 | Cyproterone acetate monotherapy in advanced prostatic carcinoma. | Int Urol Nephrol | 1997 | https://conductscience.org/library/papers/9241550 | PubMed |
| 8012037 | Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat. | Breast Cancer Res Treat | 1994 | https://conductscience.org/library/papers/8012037 | PubMed |
| 7647332 | Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. | Breast Cancer Res Treat | 1995 | https://conductscience.org/library/papers/7647332 | PubMed |
| 3926197 | Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/3926197 | PubMed |
| 3718913 | Ocular toxicity of Anandron in patients treated for prostatic cancer. | Br J Ophthalmol | 1986 | https://conductscience.org/library/papers/3718913 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3916740
GET https://conductscience.org/api/papers/v1/3916740/cited_by?page=2